tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Corvus Pharmaceuticals’ Promising Study on Soquelitinib for Atopic Dermatitis
PremiumCompany AnnouncementsCorvus Pharmaceuticals’ Promising Study on Soquelitinib for Atopic Dermatitis
2M ago
Corvus announces IND application approved by CDE of China NMPA to start trial
Premium
The Fly
Corvus announces IND application approved by CDE of China NMPA to start trial
2M ago
Corvus Pharmaceuticals Holds Annual Stockholders Meeting
Premium
Company Announcements
Corvus Pharmaceuticals Holds Annual Stockholders Meeting
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Corvus Pharmaceuticals Reports Strong Q1 2025 Earnings
Premium
Company Announcements
Corvus Pharmaceuticals Reports Strong Q1 2025 Earnings
4M ago
Corvus Pharmaceuticals price target raised to $17 from $15 at Oppenheimer
Premium
The Fly
Corvus Pharmaceuticals price target raised to $17 from $15 at Oppenheimer
4M ago
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Corvus Pharmaceuticals Appoints New Director to Board
Premium
Company Announcements
Corvus Pharmaceuticals Appoints New Director to Board
5M ago
Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Corvus Pharmaceuticals’ Earnings Call: Progress Amid Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100